𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response

✍ Scribed by M. Moreno; R. Pérez-Alvarez; L. Rodrigo; R. Pérez-López; P. Suárez-Leiva


Book ID
108885813
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
121 KB
Volume
13
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Excess liver-related morbidity of chroni
✍ Hamish A. Innes; Sharon J. Hutchinson; Samuel Allen; Diptendu Bhattacharyya; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Our objective was to address two shortfalls in the hepatitis C virus (HCV) literature: (1) Few data exist comparing post-treatment liver-related mortality/morbidity in HCV-sustained virologic response (SVR) patients to non-SVR patients and (2) no data exist examining liver-related morbidity among tr

Corrections: Excess liver-related morbid
📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

In the August 2011 issue of HEPATOLOGY, in the article entitled ''Carcinogen-induced hepatic tumors in KLF6þ/À mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation'' (volume 54, pages 522-531), Dr.

Excess mortality in patients with advanc
✍ Adrian M. Di Bisceglie; Anne M. Stoddard; Jules L. Dienstag; Mitchell L. Shiffma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

for the HALT-C Trial Group Chronic hepatitis C virus infection can cause chronic liver disease, cirrhosis and liver cancer. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial was a prospective, randomized controlled study of long-term, low-dose peginterferon therapy in pa